The counterfeit drug market worldwide is a grave threat to public health because the medicines sold are sub-standard resulting in a lot of deaths.
Through an investment from Acumen Fund, Sproxil is combating the global counterfeit drug market through a Mobile Product Authentication™ (MPA™) solution that enables consumers to verify the authenticity of pharmaceutical products.
Sproxil’s MPA solution allows customers to send a free text message containing a code found on a drug to Sproxil’s servers, which immediately respond and indicate whether the drug is genuine or fake. Sproxil has set up Africa’s first national mobile-based anti-counterfeit service in Nigeria, and Acumen Fund’s investment will enable the spielautomaten online company to expand into Kenya and India.
It is a simple solution. Customers get a scratch card with a one-time user code. To verify a product, they send the code via SMS to a 911 for fake drugs number. Sproxil either sends a response authenticating the drug or sends a hotline number for customers to call and report the drug if it is found to be fake.
The complete case study of this project is available here.
